Evicenter
MarkdownMedical informationP&T meetings
Lonimecgene renparvovec (TSHA-102)

Rett syndrome

Launch
Not announced
Last updated
199 sources

Product information and disease descriptionPlace of product in therapyApproaches to treatment

Ongoing post-approval monitoring

2 evidence topics · 2 sources

Post-approval monitoring commitments for TSHA-102

No evidence found.